申请人:Kunming Institute of Botany, The Chinese Academy of Sciences
公开号:US20160083364A1
公开(公告)日:2016-03-24
The present invention relates to the pharmaceutical field, in particular to a phenanthridine derivative as shown in general formula (1)
a pharmaceutical composition comprising the derivative, its preparation method, and its uses in manufacture of a medicament for the prevention or treatment of a disease related to the activity of Wnt signaling pathway, hepatitis C and hepatitis B.
本发明涉及制药领域,特别是一种如通用式(1)所示的苯并三氮杂环衍生物,包括该衍生物的药物组合物、其制备方法,以及其在制备与Wnt信号通路活性、丙型肝炎和乙型肝炎相关疾病的预防或治疗药物中的用途。